Booster vaccination with inactivated whole-virus or mRNA vaccines and COVID-19–related deaths among people with multimorbidity: a cohort study-Reference-Cited by-同舟云学术

Booster vaccination with inactivated whole-virus or mRNA vaccines and COVID-19–related deaths among people with multimorbidity: a cohort study

Published:2023-01-29 Issue:4 Volume:195 Page:E143-E152
ISSN:0820-3946
Container-title:Canadian Medical Association Journal
language:en
Short-container-title:CMAJ

Author:

Lai Francisco Tsz Tsun,Yan Vincent Ka Chun,Ye Xuxiao,Ma Tiantian,Qin Xiwen,Chui Celine Sze Ling,Li Xue,Wan Eric Yuk Fai,Wong Carlos King Ho,Cheung Ching Lung,Li Philip Hei,Cheung Bernard Man Yung,Lau Chak Sing,Wong Ian Chi Kei,Chan Esther Wai Yin

Publisher

CMA Impact Inc.

Subject

General Medicine

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Effectiveness of post-COVID-19 primary care attendance in improving survival in very old patients with multimorbidity: a territory-wide target trial emulation;Family Medicine and Community Health;2024-07

2. Safety and immunogenicity of COReNAPCIN, a SARS-CoV-2 mRNA vaccine, as a fourth heterologous booster in healthy Iranian adults: A double-blind, randomized, placebo-controlled, phase 1 clinical trial with a six-month follow-up;International Immunopharmacology;2024-06

3. Population-Based Evaluation of Vaccine Effectiveness against SARS-CoV-2 Infection, Severe Illness, and Death, Taiwan;Emerging Infectious Diseases;2024-03

4. Long-Term Immunogenicity and Safety of a Homologous Third Dose Booster Vaccination with TURKOVAC: Phase 2 Clinical Study Findings with 32-Week Post-Booster Follow-Up;Vaccines;2024-01-29

5. Effectiveness and Respiratory Adverse Events Following Inactivated and mRNA COVID-19 Vaccines in Patients with COPD and Asthma: A Chinese Population-Based Study;Drug Safety;2023-12-12